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Background: On two farms it was noted that after routine treatment with monepantel, fecal egg counts failed to
drop. This was accompanied by lambs mortality due to Haemonchus contortus infection. The aim of this work was
to evaluate the efficacy of monepantel to control gastrointestinal nematodes (GIN) in two sheep farms, in Uruguay.
Findings: A Fecal Egg Count Reduction Test (FECRT) was subsequently performed at the Experimental Stations
Glencoe of INIA Tacuarembó (Farm 1) and Sheep Unit of INIA La Estanzuela (Farm 2) using the World Association
for the Advancement of Veterinary Parasitology guidelines. On Farm 1 the FECRT was performed using 6–8 month
old Corriedale or Merino Dohne x Corriedale male lambs naturally infected with GIN. On day 0 pre-treatment, three
groups of 15 lambs each were selected, blocked by fecal egg count level (FEC) and randomly assigned to one of
the following: Group 0 = untreated control, Group 1 = treated with monepantel (Zolvix®, Novartis Animal Health Inc.)
from stock previously purchased; Group 2 = treated with monepantel from stock provided by the supplier, at the
recommended dose of 2.5 mg/kg of body weight. Fecal samples were collected directly from the rectum from each
lamb on day 0 and on day 9 post-treatment. On Farm 2, the FECRT was conducted on a group of 8 month old
male lambs Milchschaff x Finn. At this farm, 10 lambs were randomly allocated to be treated with monepantel
(Group 1) and 10 lambs were randomly allocated to remain as untreated control (Group 0) using the same
protocols as Farm 1.
On farm 1 the FECR was 0.0% (95% CI = 0.0 – 49.0) and 42.0% (95% CI = 0.0 – 75.0) for Group 1 and Group 2
respectively. For Farm 2, the FECR was 82.1% (95% CI = 36.0 – 99.0). Haemonchus spp was the resistant genus.
Conclusions: Poor effcicacy of monepantel in treating GIN parasites was demonstrated on both farms.
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Background
In Uruguay, ovine production plays a very important
role in the economy. Parasitism due to gastrointestinal
nematodes (GIN) is one of the most important health
constraints affecting sheep rearing operations and its
control has relied primarily on the use of chemical drugs.
As a result, anthelmintic resistance (AR) is a wide-spread
phenomenon amongst sheep farms in this country. A
national survey conducted between 1994 and 1995 to
quantify the prevalence of anthelmintic resistance (AR)
in sheep GIN [1], revealed that benzimidazole (BZ), lev-
amisole (LEV) and ivermectin (IVM) resistance was* Correspondence: amederos@inia.org.uy
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unless otherwise stated.present on 80%, 71% and 1.2% respectively, of the studied
sheep farms (n = 252). Subsequently, several reports from
different diagnostic laboratories established that the pre-
valence of AR continues to escalate. In 2005, results from
a sample of 130 sheep farms revealed that 89% had re-
sistance to IVM, 82% to LEV, 89% to closantel and 29%
to moxidectin [2]. In both studies, Haemonchus sp and
Trichostrongylus spp were the main genera reported as
resistant.
After many years, a new class of anthelmintic, the
amino-acetonitrile derivative monepantel (Zolvix, Novartis
Animal Health Inc.) was developed for the control of
GIN in sheep [3]. Monepantel was first available in
New Zealand in 2009 and became commercially avail-
able in Uruguay in 2010. The first report of AR to mon-
epantel was reported from New Zealand in 2013 as aal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Trichostrongylus colubriformis in goats [4].
The objective of this study was to evaluate the suspi-
cion of poor efficacy of monepantel against gastrointes-
tinal nematodes on two sheep farms at the National
Research Institute for Agriculture (INIA), in Uruguay.
Methods
The studied farms
The study was conducted at the Experimental Stations
Glencoe of INIA Tacuarembó (Farm 1), and INIA La
Estanzuela (Farm 2), Colonia, Uruguay. Farm 1 is an ex-
tensive sheep and cattle production farm, occupying
1300 ha and located southwest of Uruguay (32° 00’24”S,
57° 08’ 01” W). The farm maintains three sheep flocks:
Australian Merino (n = 977), Corriedale (n = 258) and
Merino Dohne and their crosses (n = 883). The gastro-
intestinal parasite control program is based on fecal egg
count monitoring and anthelmintic treatment when in-
dicated by high fecal egg counts. History of monepantel
use on this farm was investigated to describe possible
risk factors present for development of AR.
Farm 2 is located in the southwest region of Uruguay
(34°19´57´´S, 57°40´07´´W) and is an intensive sheep pro-
duction system (n = 2250 to 2500) occupying 100 ha with
one flock comprised of multiple breeds mainly Milchschaf,
Finn, Texel and Polwarth. Gastrointestinal parasite control
is based on FAMACHA scoring [5,6] and targeted selec-
tive treatment of sheep scoring “4” or “5”. History of mon-
epantel use on this farm was also investigated.
Multidrug AR (benzimidazole, levamisole, ivermectin
and closantel) was diagnosed on both farms by FECRT
performed on a routine base, with Haemonchus contor-
tus being the main gastrointestinal nematode diagnosed
(unpublished data).
Sheep trade between both farms has been rare.
Fecal egg count reduction test
Fecal egg count reduction tests (FECRT) were carried
out using the World Association for the Advancement
of Veterinary Parasitology (WAAVP) guidelines [7,8]. On
Farm 1 at the initial visit designated day −6 (May 14th,
2014), a total of 123 Corriedale and Merino Dohne ×
Corriedale 6–8 month old castrated male lambs naturally
infected with gastrointestinal nematodes and not having
been treated with any anthelmintic in 30 days, were
weighed and individual fecal samples were taken dir-
ectly from the rectum. The samples were identified with
ear tag number and transported refrigerated to the labora-
tory and processed immediately after arrival. Results were
used to assign lambs to treatment groups.
On day 0 pre-treatment (May 20th, 2014), three groups
of 15 lambs each were selected, blocked by fecal egg count
level (FEC) and randomly assigned to one of the following:Group 0 = untreated control (G0), Group 1 = treated with
monepantel (Zolvix®, Novartis Animal Health Inc.) from
stock previously purchased (G1); Group 2 = treated with
monepantel (Zolvix®, Novartis Animal Health Inc.), from
stock provided by the supplier (G2).
Lambs assigned to G1 and G2 were drenched orally
using a syringe at the corresponding drug dose accord-
ing to their body weight, while lambs from G0 received
no treatment. At the same time, fecal samples were col-
lected directly from the rectum from each lamb, placed
in a plastic bag, sealed after air removal, identified with
ear tag, placed in a cooler and transported to the lab.
On day 9 post-treatment (May 29th, 2014) a second
fecal sample from all lambs was taken and transported
following the same procedure previously described.
At Farm 2, the FECRT was conducted to evaluate five
drugs, but here we will describe only the monepantel
evaluation. For this purpose, eight month old male lambs
Milchschaff × Finn were randomly selected (n = 20) and
10 were randomly allocated to remain untreated as a
control (Group = 0) and 10 lambs were randomly allo-
cated to be treated with monepantel (Group = 1). From
here, everything was performed according to the proto-
col described above.
All samples were processed at INIATacuarembó Animal
Health Laboratory. Fecal egg counts were performed using
a modified McMaster technique [9] with a lower detection
limit of 50 eggs per gram. Coprocultures were performed
using pooled fecal samples: the pre-treatment sampling at
day 0 (G0, G1 and G2 combined), and subsequently one
for each group at the post-treatment sampling at day 9.
The cultures were placed at 27°C during 10 days and then
transferred to Baermann apparatus, recovered after 24h
and kept refrigerated at 4°C until analysis using standard
identification keys [9,10].
Analysis and results interpretation
The formula described by Dash (1988) [11] was used to
estimate flock FECR, based on arithmetic means fecal
egg counts in controls (C) and treated (T) animals:
FECR ¼ 100 1– T2=T1½  C1=C2½ ð Þ;




At day −6 pre-treatment the mean FEC after sorting the
groups were 3010, 3530 and 3717 eggs per gram and the
mean body weight 29 kg, 27 kg and 28 kg for the lambs
of G0, G1 and G2, respectively.
The results presented in Table 1, supports the hypo-
thesis that monopantel lacks sufficient efficacy to reduce
Table 1 Results of the mean fecal egg counts pre and
post-treatment for all groups and %FECR for the








G0 = Control 3307 5490 NA
G1 =Monepantel1 Lab 3020 5132 0.0 (0.0 – 49.0)
G2 =Monepantel New 5117 5114 42.0 (0.0 – 75.0)
Farm 2
G0 = Control 6875 6345 NA
G1 =Monepantel Lab 2880 475 82.1 (36.0 – 99.0)
FEC = fecal egg counts; %FECR = percentage fecal egg counts reduction;
NA = not applicable.
1Zolvix (Novartis Animal Health Inc.).
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mintic resistance to monepantel exists in that parasite
population.
Farm 2
The results presented in Table 1, demonstrated that both
the %FECR and the 95% confidence interval were below
the limit established for adequate efficacy by the WAAVP
guidelines. Results from coprocultures revealed that Hae-
monchus spp. was the main genus that developed in mon-
epantel groups (see Table 2).
History of Monepantel use
Historical use of monepantel was considered retrospec-
tively as a possible risk factor for development of anthel-
mintic resistance. On Farm 1, the first treatment with
monepantel was given in March 2011 (autumn); a second
treatment was given in August and a third in December to
the whole ewe flocks. Subsequently, during 2012, a single
drench was administered to all the lambs and all breeding
ewes received two drenches (before lambing and nursing).Table 2 Results of the percentage of gastrointestinal nemato
both farms
Group Time Haemonchus sp. %
Farm 1
Control Day 0 86
Control Day10 92
Monepantel1 Lab Day10 100
Monepantel New Day10 100
Farm 2
Control Day 0 4
Control Day10 28
Monepantel Lab Day10 93
1Zolvix (Novartis Animal Health Inc.).However, during 2013 the drug was used more frequently,
being all lambs and all ewes the group that received three
treatments based on fecal egg counts.
On Farm 2, monepantel use started in May 2011, but
here sheep and lambs were selectively treated based on
routine FAMACHA scoring for anemia and the propor-
tion of the flock that required treatment varied from 5%
to 10%. Paddocks management in both farms is very com-
plex in comparison with commercial sheep farms, due to
the various production and experimental trials performed.
Therefore, retrospective unbiased results about potential
causal factors could not be obtained.
Discussion
The results presented above demonstrated that on two
farms, a multidrug resistant strain of Haemonchus con-
tortus (unpublished observations) developed apparent
resistance to monepantel as evidence by treatment fail-
ure assessed using a FECRT. Resistance to monepantel
has also been reported in New Zealand [4,5], but in that
case monepantel failed to control Teladorsagia circum-
cincta and Trichostrongylus colubriformis in goats. In
New Zealand monepantel was licensed in 2009 and re-
sistance was reported four years later, similar to what
has now happened in Uruguay since monepantel was li-
censed in 2010 and resistance detected in 2014. Previous
research has demonstrated an AAD mutant gene present
in a sub-population of H. contortus [3,13]. The results of
this investigation support the presence of this gene in
the field through its apparent phenotypic expression on
these two farms. To confirm the presence of this gene,
Haemonchus spp. isolates from the coprocultures and
adult worms would need to be further examined. In ad-
dition to the FECRT, other methods to detect multidrug
anthelmintic resistence might be explored, as recently
proposed by Roeber et al. [14].
On both Farm 1 and Farm 2, the frequency of monepan-
tel use was low prior to experiencing apparent treatmentdes genera identified from the coprocultures at
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lation in refugia are the main risk factors for AR deve-
lopment most commonly incriminated in the literature.
Based on the history available, these factors do not seem
to be important here. As mentioned above, on Farm 1,
monepantel was seldom used from 2011 to 2012 and ap-
plied three times to all animals from the same flock during
2013. On Farm 2, all treatments were applied using tar-
geted selective treatment based on FAMACHA scoring,
thus not eliminating refugia due to massive treatment.
This is in concordance with a recent study that high-
lighted the lack of unbiased scientific evidence for risk fac-
tors associated with the development of AR in sheep
gastrointestinal nematodes [15].
Conclusions
The present situation of anthelmintic resistance in Uruguay
is becoming aggravated with the early development of re-
sistance to monepantel by Haemonchus spp. (putative
Haemonchus contortus). Further molecular studies are ne-
cessary to understand the mechanism of monepantel re-
sistance, allowing early detection to develop strategies to
prevent the spread of resistant worms.
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